Neuronetics, Inc.
STIM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $75 | $71 | $65 | $55 |
| % Growth | 5% | 9.4% | 17.9% | – |
| Cost of Goods Sold | $21 | $20 | $15 | $12 |
| Gross Profit | $54 | $52 | $50 | $44 |
| % Margin | 72.3% | 72.5% | 76.3% | 78.9% |
| R&D Expenses | $13 | $10 | $9 | $8 |
| G&A Expenses | $30 | $25 | $26 | $26 |
| SG&A Expenses | $76 | $73 | $75 | $63 |
| Sales & Mktg Exp. | $46 | $47 | $50 | $38 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $89 | $82 | $85 | $71 |
| Operating Income | -$35 | -$31 | -$35 | -$28 |
| % Margin | -46.2% | -42.8% | -53.8% | -49.8% |
| Other Income/Exp. Net | -$9 | $0 | -$2 | -$4 |
| Pre-Tax Income | -$44 | -$30 | -$37 | -$31 |
| Tax Expense | -$0 | -$0 | $0 | $0 |
| Net Income | -$44 | -$30 | -$37 | -$31 |
| % Margin | -58.4% | -42.3% | -57% | -56.4% |
| EPS | -1.38 | -1.05 | -1.38 | -1.22 |
| % Growth | -31.4% | 23.9% | -13.1% | – |
| EPS Diluted | -1.38 | -1.05 | -1.38 | -1.22 |
| Weighted Avg Shares Out | 32 | 29 | 27 | 25 |
| Weighted Avg Shares Out Dil | 32 | 29 | 27 | 25 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $7 | $5 | $4 | $3 |
| Depreciation & Amortization | $2 | $2 | $2 | $1 |
| EBITDA | -$34 | -$23 | -$32 | -$27 |
| % Margin | -45.9% | -31.9% | -49% | -48.5% |